Abbott shopping around for pharma growth, analysts say Sep 19, 2009
Credit Suisse names three biotechnology firms that Abbott could go after: Biomarin Pharmaceutical Inc. and Rigel Pharmaceuticals Inc., both of California, and Connecticut-based Alexion Pharmaceuticals Inc.. Crains Briefing. (Crain's Chicago Business)
R788 in TASKi3 Clinical Trial Does Not Meet Efficacy Endpoints in RA Patients Who Had Previously Failed Biologic Therapies - Results Incongruent Jul 24, 2009
Rigel Pharmaceuticals, Inc. (PRNewsFoto) SOUTH SAN FRANCISCO, CA USA ... July 23 /PRNewswire-FirstCall/ -- Rigel Pharmaceuticals, Inc. (Nasdaq: ) today announced that in the TASKi3 Phase 2b clinical trial in rheumatoid arthritis (RA) patients who had failed to respond to at least one biologic treatment, the group treated with R788 (fostamatinib disodium) did not report significantly higher ACR 20, ACR 50, ACR 70 and DAS28 response rates than the placebo group at three months, and therefore, the... (PR Newswire)
Rigel to Host Conference Call to Discuss Results of Its Phase 2b TASKi2 Clinical Trial of R788 in Rheumatoid Arthritis Jul 9, 2009
July 8 /PRNewswire-FirstCall/ -- Rigel Pharmaceuticals, Inc. (Nasdaq: ) today announced that the Company plans to host a conference call on Thursday, July 9, 2009 at 8:00 am EDT (5:00 am PDT) ... SOURCE Rigel Pharmaceuticals, Inc.. (PR Newswire)
Shareholder Class Action Filed Against Rigel Pharmaceuticals, Inc. by the Law Firm of Barroway Topaz Kessler Meltzer & Check, LLP Feb 21, 2009
Shareholder Class Action Filed Against Rigel Pharmaceuticals, Inc. by the Law Firm of Barroway Topaz Kessler Meltzer , LLP ... Shareholder Class Action Filed Against Rigel Pharmaceuticals, Inc. by the Law Firm of Barroway Topaz Kessler Meltzer , LLP ... Notice is hereby given that a class action lawsuit was filed in the United States District Court for the Northern District of California on behalf of purchasers of securities of Rigel Pharmaceuticals, Inc. (Nasdaq: ) ("Rigel" or the "Company")... (PR Newswire)
The Brualdi Law Firm, P.C. Announces Class Action Lawsuit Against Rigel Pharmaceuticals, Inc. Feb 8, 2009
NEW YORK, Feb. 6, 2009 (GLOBE NEWSWIRE) -- The Brualdi Law Firm, P.C. announces that a lawsuit has been commenced in the United States District Court for the Northern District of California on behalf of purchasers of Rigel Pharmaceuticals, Inc. (``Rigel'' or the ``Company'') (NasdaqGM: - ) securities during the period between December 13, 2007 and October 27, 2008 (the ``Class Period'') including all persons who acquired the common stock of Rigel pursuant and/or traceable to a false and... (Primezone Releases)
